Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin-clavulanic acid for chronic low back pain with lumbar disc herniation
ACTRN12615000958583Phase 2Completed
- Sponsor
- Monash University
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in lumbodynia (LBP) and Herniated Lumbar Disk comparing Amoxicillin-clavulanic acid with Placebo (2 arms). Primary endpoints: Pain intensity at 12 months, Disability at 12 months and 1 more. Started Jan 2016; status: completed.
02
Drugs
amoxicillin + clavulanate
03
Conditions
lumbodynia (LBP)Herniated Lumbar Disk
Beyond the preview
Go deeper on ACTRN12615000958583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000958583.